Table 1.
characteristics and traditional risk factors of hypertensive participants attending an HIV treatment centre, northern Tanzania, 2018 (n=91)
Demographics | |
---|---|
Age (years), mean (SD) | 51.1 (11.2) |
Sex (female), n (%) | 75 (82.4%) |
Education, n=90, n (%) | |
Primary school or less | 75 (83.3%) |
Secondary school or higher | 15 (16.7%) |
Income per month (USD), median (IQR) | 35 (17 - 67) |
HIV-related characteristics | |
HIV duration (months), n=85, median (IQR) | 46 (18 - 82) |
ART duration (months), median (IQR) | 41 (18 - 72) |
Current ART, n (%) | |
TDF, 3TC, EFV | 72 (79.1%) |
AZT, 3TC, NVP | 9 (9.9%) |
TDF, FTC, EFV | 5 (5.5%) |
Other | 5 (5.5%) |
CD4 current (cells/mm3), n=90, median (IQR) | 454 (348 - 603) |
CD4 nadir (cells/mm3), n=90, median (IQR) | 240 (117 - 382) |
HIV RNA level (copies/mL), n=80, n (%) | |
0 - 199 | 69 (86.3%) |
200 - 999 | 2 (2.5%) |
>1000 | 9 (11.3%) |
Traditional hypertension risk factors | |
Family history of hypertension (yes), n=90, n (%) | 36 (40.0%) |
Daily fruit intake (yes), n (%) | 27 (29.7%) |
Daily vegetable intake (yes), n (%) | 36 (39.6%) |
Always add salt while cooking (yes), n (%) | 76 (83.5%) |
Vigorous or moderate intensity physical activity (yes), n (%) | 78 (86.7%) |
Smoking or tobacco use history, n (%) | |
Never | 73 (80.2%) |
Former | 13 (14.3%) |
Current | 5 (5.5%) |
Alcohol use, n (%) | |
Never | 18 (19.8%) |
Former | 35 (38.5%) |
Current | 38 (41.8%) |
Current high risk, n=38 | 13 (34.2%) |
Sample size is 91 participants unless otherwise stated. Abbreviations: SD: standard deviation; USD: United States dollar; IQR: interquartile range; ART: antiretroviral therapy; TDF: tenofovir disoproxil fumarate; 3TC: lamivudine; EFV: efavirenz; AZT: zidovudine; NVP: nevirapine; FTC: emtricitabine; BMI: body mass index